2368 articles by Nick Paul Taylor
-
Bausch + Lomb recalls Envista intraocular lenses over safety risks
March 31, 2025 -
FDA OKs first at-home test for 3 STIs
March 31, 2025 -
J&J launches energy generator compatible with Ottava robot
March 28, 2025 -
Newly public Beta Bionics reports sales surge; Dexcom hires CCO
March 28, 2025 -
Abbott gets FDA nod to begin IVL trial after rivals buy up competition
March 25, 2025 -
Labcorp to close Los Angeles site, lay off 73 people
March 24, 2025 -
FDA posts early alert after Calyxo urinary stone device tied to death
March 21, 2025 -
Quest, Google team on gen AI; GE Healthcare plans autonomous imaging
March 20, 2025 -
Medtronic recalls embolization devices tied to 17 injuries, 4 deaths
March 19, 2025 -
Spectral AI algorithms beat physicians in burn tissue assessments
March 18, 2025 -
FDA adds hemodialysis devices to shortage list amid B. Braun disruption
March 17, 2025 -
Vicarious Surgical appoints Sarah Romano as CFO
March 14, 2025 -
Vivani to spin off neurostimulation business
March 13, 2025 -
FDA accuses Mid-Link of copying or falsifying medical device test data
March 12, 2025 -
ECRI warns insufficient AI governance threatens patient safety
March 11, 2025 -
Dexcom receives warning letter based on FDA inspections of 2 plants
March 10, 2025 -
FTC challenges $627M private equity takeover of Surmodics
March 7, 2025 -
Boston Scientific leads $175M investment in 4C Medical
March 6, 2025 -
Olympus recalls lung biopsy devices linked to 26 serious injuries
March 4, 2025 -
FDA recall notice details J&J pause of Varipulse
March 3, 2025 -
Medtronic partners with Brainomix on AI stroke tool
Feb. 28, 2025 -
Elekta CEO Gustaf Salford to leave after board sees need for new leader
Feb. 27, 2025 -
CAP urges HHS to revoke lab developed test rule, citing Trump order
Feb. 26, 2025 -
Quest to buy Fresenius Medical Care kidney testing assets
Feb. 25, 2025 -
Guardant accuses Natera of poaching employees, stealing trade secrets
Feb. 24, 2025